[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"myopia-progressing\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:myopia-progressing":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100615916","phase-2-clinical-efficacy-and-mechanism-exploration-of-mr-61-in-delaying-the-progression-of-myopia-100615916",false,"NCT07298824","Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia","Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","Inclusion Criteria:\n\n1. Myopia is defined as spherical equivalent (SE) ≤ -0.5D.\n2. Aged between 3 and 18 years, with no restriction on gender.\n3. Cylinder power ≤ 1.50D; anisometropia of SE between both eyes ≤ 1.50D.\n4. The subject has sufficient compliance with the study follow-up; the subject or their guardian has the intention to receive treatment and has signed the informed consent form.\n\nExclusion Criteria:\n\n1. Presence of other concomitant ocular diseases;\n2. Abnormal findings on clinical slit-lamp examination;\n3. Existence of amblyopia, manifest strabismus, esotropia, or other congenital ocular diseases;\n4. Individuals with abnormal intraocular pressure or abnormal axial length of the eye;\n5. Either or both parents having a spherical equivalent (SE) ≤ -6.00D;\n6. Other conditions inconsistent with this study.","ALL","3 Years","18 Years",{"count":20,"type":21},164,"ESTIMATED","INTERVENTIONAL",[24],"PHASE2","To investigate whether probiotic MR-61 can assist in slowing down the progression rate of myopia (a prospective randomized controlled study).",[27],"Myopia Progressing",[29],"Myopia,Probiotics,Gut microbiota","RECRUITING","2025-12-20",{"date":33,"type":34},"2025-12-23","ACTUAL",{"date":36,"type":34},"2025-10-01",{"date":38,"type":21},"2027-07-01",{"name":40,"class":41},"Second Affiliated Hospital of Nanchang University","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":50,"sex":16,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":4},"100561092","brain-visual-perception-training-for-prevention-and-control-of-premyopia-100561092","NCT06585657","Brain Visual Perception Training for Prevention and Control of Premyopia","Clinical Study on Brain Visual Perception Training for Prevention and Control of Myopia in Children with Premyopia","Inclusion Criteria:\n\nChildren aged 6-10 years with premyopia, defined as a cycloplegic spherical equivalent refraction (SER) of the more myopic eye in the range of -0.50 to 0.75 (inclusive) diopters (D) and having at least 1parent with an SER in either eye of -3.00D or less.\n\nExclusion Criteria:\n\nChildren have astigmatism of 1.50D or more, anisometropia of 1.50 D or more, strabismus and other ocular abnormalities, any systemic diseases, or a history of any myopia interventions.",true,"6 Years","10 Years",{"count":54,"type":21},156,[56],"NA","The goal of this clinical trial is to investigate whether brain visual perception training can effectively prevent myopia in children with pre myopia. It will also learn about the safety of brain visual perception training.\n\nThe main questions it aims to answer are: Does brain visual perception training slow down the growth of axial length? What medical issues may participants encounter when using the brain visual perception training system? Researchers will compare participants who receive brain visual perception training with a control group to see if the training group can delay the onset of pre myopia in children Participants will: The training group will receive 20 minutes of brain visual perception training once a day for a period of one year. Follow up check ups at the hospital every 3 months. Keep a diary of the values of axial length and refractive diopter.",[59,27],"Visual Function",[61,62],"brain visual perception training","premyopia","NOT_YET_RECRUITING","2024-09-09",{"date":66,"type":34},"2024-09-19",{"date":68,"type":21},"2024-09-15",{"date":70,"type":21},"2026-03-31",{"name":72,"class":41},"Shanghai Eye Disease Prevention and Treatment Center"]